EFM
GTHX

E Fund Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

E Fund Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,869
Closed -$98K – 354
2022
Q1 		$98K Buy
12,869
+1,542
+14% +$14.6K ﹤0.01% 315
2021
Q4 		$116K Sell
11,327
-280
-2% -$3.57K ﹤0.01% 285
2021
Q3 		$156K Buy
+11,607
New +$189K 0.01% 247

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

E Fund Management's GTHX Position: Q2 2022 in Review

E Fund Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 12,869 shares — an estimated $98K sold.

E Fund Management first reported a position in GTHX in Q3 2021 and held it in 3 quarters. The position peaked at $156K in Q3 2021. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • E Fund Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • E Fund Management sold 12,869 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $98K.
  • E Fund Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • E Fund Management's G1 Therapeutics, Inc. Common Stock position peaked at $156K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.